A highly significant and non-dose dependent 3-fold increase in p-AVP was measured after all three doses of tolvaptan (Fig. 3 ).
← all excerpts
Effect of tolvaptan on renal water and sodium excretion and blood pressure during nitric oxide inhibition: a dose-response study in healthy subjects.
1
—
—